24/7 Market News Snapshot 09 April, 2025 – Microbot Medical, Inc. Common Stock (NASDAQ:MBOT)

April 9, 2025

DENVER, Colo., 09 April, 2025 (www.247marketnews.com) – (NASDAQ:MBOT) are discussed in this article.
Microbot Medical, Inc. is experiencing a significant surge in investor interest, as evidenced by a remarkable 36.04% increase in its stock price, which has risen to $1.891 in pre-market trading. This spike follows the company’s recent announcement regarding breakthrough results from its ACCESS-PVI pivotal trial of the LIBERTY® Endovascular Robotic System, showcased at a major industry conference. The trial outcomes reveal a perfect 100% success rate in robotic navigation during endovascular procedures across 20 cases at three prestigious medical institutions, highlighting a pivotal advancement in patient care.

In addition to successfully meeting its primary endpoint, the LIBERTY® system achieved a notable 92% reduction in radiation exposure, enhancing safety for both patients and healthcare providers. Dr. Francois Cornelis, a respected interventional radiologist who presented the trial data, emphasized the system’s potential to transform endovascular procedures. With an average robotic navigation time of only three minutes and a 100% satisfaction rate from participating clinicians, the feedback underscores the device’s user-friendly design and effectiveness.

Harel Gadot, Chairman, CEO, and President of Microbot Medical, expressed optimism about the study’s findings. He affirmed the commitment of the team to the development of LIBERTY® and articulated confidence in its ability to revolutionize interventional medicine as it approaches commercial launch. Dr. Juan Diaz-Cartelle, the Chief Medical Officer, echoed these sentiments, emphasizing the encouraging clinical data and the positive reception from investigators regarding the device’s intuitive operation.

As Microbot Medical advances toward regulatory approval for the LIBERTY® Endovascular Robotic System, it is poised for collaboration with interventional physicians and healthcare providers, striving to establish a new paradigm in patient care on a global scale.

Related news for (MBOT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.